Summary of Key Points Core Viewpoint - The company, Jiangsu Xiangteng New Materials Co., Ltd., has received approval to use its own funds to pay for part of the fundraising investment projects and will subsequently replace these with equivalent amounts from the raised funds, ensuring compliance with relevant regulations and maintaining project efficiency [1][7]. Group 1: Fundraising Overview - The company issued 17,171,722 shares at a price of RMB 28.93 per share, raising a total of RMB 496.78 million, with a net amount of RMB 464.49 million after deducting underwriting and other fees [1][2]. - The company has established a special account for the raised funds and signed a tripartite supervision agreement with the bank and the sponsor [2]. Group 2: Investment Project Details - The total investment for the projects is RMB 501.76 million, with an actual planned use of raised funds amounting to RMB 442.34 million [3]. Group 3: Reasons for Using Own Funds - The company faced challenges in directly using raised funds for payroll and other expenses due to regulatory requirements, necessitating the use of its own funds initially [4][5]. - Payments for social insurance, housing funds, and taxes must be made through a unified bank account, complicating the use of multiple accounts for raised funds [4]. - The need for foreign currency payments for overseas purchases and customs duties further limited the use of the raised funds account [5]. Group 4: Operational Process for Fund Replacement - The company plans to use its own funds for project payments and will replace these with raised funds within six months, following a defined approval and replacement process [6]. - The financial department will manage the replacement process, ensuring compliance with the established procedures [6]. Group 5: Impact on the Company - The use of own funds for project payments is aligned with regulatory requirements and is expected to enhance fund utilization efficiency without affecting the normal implementation of the projects [6][7]. Group 6: Approval Process - The board of directors and the supervisory board approved the proposal to use own funds for project payments on July 24, 2025, without needing shareholder approval [6]. Group 7: Sponsor's Verification Opinion - The sponsor, Everbright Securities, confirmed that the decision-making process was followed correctly and that the use of own funds for project payments complies with relevant laws and regulations [7].

一、2021 年度向特定对象发行股票募集资金的基本情况 根据中国证券监督管理委员会出具的《关于同意万达信息股份有限公司向 特定对象发行股票注册的批复》（证监许可20221689 号），公司向特定对象 发行人民币普通股股票（A 股）255,607,229 股，面值为每股人民币 1 元，发行 价格为每股人民币 7.74 元，截至 2023 年 1 月 9 日止，公司本次向特定对象发 行股票（以下简称"本次发行"）募集资金总额为人民币 1,978,399,952.46 元， 扣除本次发行费用（不含税）人民币 26,256,654.78 元，募集资金净额为人民币 合伙）对公司本次发行募集资金的到位情况进行了审验，并于 2023 年 1 月 10 日出具了《验资报告》（信会师报字2023第 ZA10006 号）。公司已对本次发 行的募集资金进行专户存储管理，并与专户银行、保荐机构签订了募集资金三 方（四方）监管协议，对本次向特定对象发行股票募集资金进行监管。 二、募集资金投资项目的基本情况 发行募集资金预计不超过 300,000.00 万元（含 300,000.00 万元），扣除发行费 用后，募集资金净额将全部用于以下 ...

Group 1 - The core point of the announcement is the approval by the Supervisory Board of China General Nuclear Power Corporation to use funds raised from convertible bonds to replace self-raised funds already invested in projects and to cover issuance costs [1][2] - The meeting was held on July 14, 2025, and the proposal received unanimous approval with 5 votes in favor and no votes against or abstaining [1] - The Supervisory Board believes that the use of raised funds aligns with the company's development needs and will enhance capital utilization efficiency, complying with relevant regulations from the China Securities Regulatory Commission and Shenzhen Stock Exchange [1]

Core Viewpoint - China General Nuclear Power Corporation (CGN) is issuing convertible bonds to replace self-raised funds previously invested in projects and to cover issuance costs, with a total fundraising amount of RMB 490 million [7][10]. Group 1: Company Responsibilities - The company is responsible for preparing the special explanation regarding the replacement of self-raised funds with the proceeds from the convertible bonds, ensuring the information is true, accurate, and complete [2][11]. - The preparation of the special explanation is in accordance with the regulations set by the China Securities Regulatory Commission (CSRC) and the Shenzhen Stock Exchange [8][11]. Group 2: Fundraising Details - The company plans to issue 49 million convertible bonds with a face value of RMB 100 each, resulting in a total fundraising amount of RMB 490 million, after deducting issuance costs of RMB 2.1581 million [7][10]. - The net amount raised after costs is RMB 489.78419 million, which has been deposited into a designated account [7][10]. Group 3: Use of Proceeds - The net proceeds from the bond issuance will be used for specific investment projects as outlined in the fundraising plan [9][10]. - Prior to the bond proceeds being available, the company has already invested RMB 972.43963 million of its own funds into the projects from June 22, 2024, to July 14, 2025, with RMB 489.78419 million planned for replacement [10]. Group 4: Issuance Costs - The company has incurred issuance costs totaling RMB 0.2968 million, with a net amount of RMB 0.2685 million planned for replacement using the bond proceeds [10]. - The breakdown of issuance costs includes underwriting fees, legal fees, audit fees, and other related expenses [10]. Group 5: Verification and Conclusion - KPMG Huazhen LLP has conducted a verification of the fundraising and issued a report confirming that the special explanation reflects the situation accurately as of July 14, 2025 [6][11]. - The company asserts that the information disclosed complies with the relevant regulations and accurately reflects the use of self-raised funds [11].

华泰联合证券有限责任公司 关于华电新能源集团股份有限公司 使用募集资金置换预先投入募投项目自筹资金、募投项目 实施主体调整及募投金额分配额度确认的核查意见 华泰联合证券有限责任公司（以下简称"华泰联合证券"或"保荐机 构"）作为华电新能源集团股份有限公司（以下简称"华电新能"、"公司" 或"发行人"）首次公开发行股票并在主板上市的联席保荐机构，根据《证券 发行上市保荐业务管理办法》《上市公司募集资金监管规则》《上海证券交易 所股票上市规则》《上海证券交易所上市公司自律监管指引第 1 号——规范运 作》等法律法规的规定，对华电新能使用募集资金置换预先投入募投项目自筹 资金、募投项目实施主体调整及募投金额分配额度确认的事项进行审慎核查， 具体核查情况如下： 一、募集资金基本情况 根据中国证券监督管理委员会 2025 年 5 月 16 日核发的《关于同意华电新 能源集团股份有限公司首次公开发行股票注册的批复》（证监许可〔2025〕 券交易所上市（以下简称"本次发行"）。本次发行的发行价格为 3.18 元/股， 本次发行募集资金总额 15,801,242,600.52 元（超额配售选择权行使前），扣减 发行费用（不含 ...

Core Viewpoint - The company has conducted a supervisory meeting to approve the use of temporarily idle raised funds for cash management and to replace self-raised funds with raised funds for issuance-related expenses, ensuring compliance with relevant regulations [1][2]. Group 1: Cash Management - The supervisory board approved the use of temporarily idle raised funds for cash management, which is expected to enhance the efficiency of fund utilization and generate investment returns for the company and its shareholders [1]. - The decision followed necessary review procedures and is deemed legal and compliant, with no adverse impact on shareholder interests, particularly for minority shareholders [1]. Group 2: Fund Replacement - The supervisory board also approved the replacement of self-raised funds with raised funds for issuance-related expenses, with the replacement occurring within six months of the funds being received [2]. - This action is considered compliant with regulations and will not affect the normal use of the raised funds, ensuring no change in the intended use that could harm shareholder interests [2].

Summary of Key Points Core Viewpoint - The report from CITIC Securities provides a thorough examination of Suzhou Huazhi Jie Telecommunications Co., Ltd.'s use of raised funds to replace previously paid issuance expenses, confirming compliance with relevant regulations and ensuring no detriment to shareholder interests [1][6]. Group 1: Fundraising Overview - The company successfully issued 25,000,000 shares at a price of RMB 19.88 per share, raising a total of RMB 444,164,357.75, with a net amount of RMB 444,164,357.75 after deducting issuance costs [2][3]. - The funds raised are to be fully allocated to investment projects as outlined in the company's prospectus, with total project investment amounting to RMB 486,085,800 [2][4]. Group 2: Fund Allocation and Adjustments - Due to the actual net amount raised being lower than the planned investment, the company will adjust the allocation of funds while maintaining the intended use, with the shortfall to be covered by self-raised funds [2][4]. - The company pre-paid issuance expenses amounting to RMB 5,519,600 using self-raised funds [3][4]. Group 3: Compliance and Verification - The board and supervisory committee approved the use of raised funds to replace previously paid expenses, confirming adherence to regulatory requirements [4][5]. - The accounting firm Tianjian provided verification, affirming that the company's actions comply with the relevant regulations and accurately reflect the situation regarding the pre-paid expenses [5][6].

Core Points - The company has announced the use of raised funds to replace previously paid issuance expenses amounting to 5.5196 million yuan (excluding VAT), which complies with the regulation of replacement within six months after the funds are received [1][2][3] Fundraising Overview - The China Securities Regulatory Commission approved the company's initial public offering (IPO) on April 9, 2025, allowing the company to issue 25 million shares at a price of 19.88 yuan per share, raising a total of 497 million yuan [1][2] - After deducting issuance expenses, the net amount raised was 444.164 million yuan, which is lower than the total planned investment of 486.0858 million yuan for the fundraising projects [2][3] Investment Project Adjustments - The company held board and supervisory meetings on July 16, 2025, to adjust the planned investment amounts for the fundraising projects without changing the intended use of the funds [2][3] - The total investment for the projects remains at 48,608.58 million yuan, with the adjusted amount for the raised funds set at 44,416.44 million yuan [2] Compliance and Verification - The board and supervisory meetings confirmed that the use of raised funds to replace paid issuance expenses adheres to relevant regulations and does not affect the normal implementation of fundraising projects [3][4] - The accounting firm Tianjian provided verification that the company's management's report on the prepayment of issuance expenses aligns with regulatory requirements [4][6]

公司首次公开发行股票募集资金净额用于以下募投项目： 单位：万元 注 国金证券股份有限公司 关于厦门特宝生物工程股份有限公司 使用自有资金支付募投项目所需资金并以募集资金等额 置换的核查意见 国金证券股份有限公司（以下简称"保荐机构"）作为厦门特宝生物工程股份 有限公司（以下简称"公司"或"特宝生物"）首次公开发行股票并在科创板上市 的保荐机构，根据《证券发行上市保荐业务管理办法》《上海证券交易所科创板股 票上市规则》《上海证券交易所科创板上市公司自律监管指引第1号——规范运作》 等相关规定，对特宝生物使用自有资金支付募投项目所需资金并以募集资金等额置 换的事项进行了核查，核查情况及核查意见如下： 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意厦门特宝生物工程股份有限公司首次 公开发行股票注册的批复》（证监许可〔2019〕2828 号）核准，并经上海证券交易 所"自律监管决定书〔2020〕21 号"批准，公司向社会首次公开发行人民币普通股 （A 股）4,650 万股，每股发行价为 8.24 元，本次募集资金总额为人民币 38,316.00 万元，根据有关规定扣除发行费用 5,271.37 万元后，实 ...

Group 1 - The core viewpoint of the article is that Citic Securities has conducted a verification of the use of raised funds by Ying Shi Innovation Technology Co., Ltd. to replace self-raised funds that were pre-invested in fundraising projects and already paid issuance expenses [1][5] - The total amount of funds raised in the initial public offering (IPO) is 1,938.07 million RMB, with a net amount of 1,747.77 million RMB after deducting issuance expenses [1][2] - The company has signed a fundraising supervision agreement with the sponsor and the commercial bank where the raised funds are stored, ensuring proper management of the funds [2] Group 2 - The investment projects funded by the raised funds include the construction of an intelligent imaging equipment production base and the establishment of a research and development center in Shenzhen, with a total investment scale of 463.78 million RMB [3] - The company has pre-invested a total of 205.87 million RMB in fundraising projects using self-raised funds, which will be replaced by the raised funds [3][4] - The total amount of self-raised funds to be replaced for pre-invested projects and paid issuance expenses is 209.32 million RMB, with 195.43 million RMB for projects and 13.89 million RMB for issuance expenses [4][5] Group 3 - The company has completed the necessary procedures for the use of raised funds, which have been approved by the board of directors and the supervisory board, and verified by the accounting firm [5] - The verification report from the accounting firm confirms that the use of raised funds complies with relevant regulations and the company's fundraising management system [5]